Request for Covid-19 Impact Assessment of this Report
The United States Finasteride Oral Tablet market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Finasteride Oral Tablet market, reaching US$ million by the year 2028. As for the Europe Finasteride Oral Tablet landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Finasteride Oral Tablet players cover Merck, Accord Healthcare UK, Relonchem, and Sandoz, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Finasteride Oral Tablet market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
1mg Tablet
5mg Tablet
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Benign Prostatic Hyperplasia
Male Pattern Baldness
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Merck
Accord Healthcare UK
Relonchem
Sandoz
Teva Generics
Cipla
Dr. Reddy
Aurobindo Pharma
Henan Topfond
Zhejiang CONBA Pharmaceutical
Shandong Renhetang Pharmaceutical
Guangdong Eashu Pharmacetical
Shanghai Shyndec Pharmaceutical Co.,Ltd.
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Finasteride Oral Tablet Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Finasteride Oral Tablet by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Finasteride Oral Tablet by Country/Region, 2017, 2022 & 2028
2.2 Finasteride Oral Tablet Segment by Type
2.2.1 1mg Tablet
2.2.2 5mg Tablet
2.3 Finasteride Oral Tablet Sales by Type
2.3.1 Global Finasteride Oral Tablet Sales Market Share by Type (2017-2022)
2.3.2 Global Finasteride Oral Tablet Revenue and Market Share by Type (2017-2022)
2.3.3 Global Finasteride Oral Tablet Sale Price by Type (2017-2022)
2.4 Finasteride Oral Tablet Segment by Application
2.4.1 Benign Prostatic Hyperplasia
2.4.2 Male Pattern Baldness
2.4.3 Others
2.5 Finasteride Oral Tablet Sales by Application
2.5.1 Global Finasteride Oral Tablet Sale Market Share by Application (2017-2022)
2.5.2 Global Finasteride Oral Tablet Revenue and Market Share by Application (2017-2022)
2.5.3 Global Finasteride Oral Tablet Sale Price by Application (2017-2022)
3 Global Finasteride Oral Tablet by Company
3.1 Global Finasteride Oral Tablet Breakdown Data by Company
3.1.1 Global Finasteride Oral Tablet Annual Sales by Company (2020-2022)
3.1.2 Global Finasteride Oral Tablet Sales Market Share by Company (2020-2022)
3.2 Global Finasteride Oral Tablet Annual Revenue by Company (2020-2022)
3.2.1 Global Finasteride Oral Tablet Revenue by Company (2020-2022)
3.2.2 Global Finasteride Oral Tablet Revenue Market Share by Company (2020-2022)
3.3 Global Finasteride Oral Tablet Sale Price by Company
3.4 Key Manufacturers Finasteride Oral Tablet Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Finasteride Oral Tablet Product Location Distribution
3.4.2 Players Finasteride Oral Tablet Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Finasteride Oral Tablet by Geographic Region
4.1 World Historic Finasteride Oral Tablet Market Size by Geographic Region (2017-2022)
4.1.1 Global Finasteride Oral Tablet Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Finasteride Oral Tablet Annual Revenue by Geographic Region
4.2 World Historic Finasteride Oral Tablet Market Size by Country/Region (2017-2022)
4.2.1 Global Finasteride Oral Tablet Annual Sales by Country/Region (2017-2022)
4.2.2 Global Finasteride Oral Tablet Annual Revenue by Country/Region
4.3 Americas Finasteride Oral Tablet Sales Growth
4.4 APAC Finasteride Oral Tablet Sales Growth
4.5 Europe Finasteride Oral Tablet Sales Growth
4.6 Middle East & Africa Finasteride Oral Tablet Sales Growth
5 Americas
5.1 Americas Finasteride Oral Tablet Sales by Country
5.1.1 Americas Finasteride Oral Tablet Sales by Country (2017-2022)
5.1.2 Americas Finasteride Oral Tablet Revenue by Country (2017-2022)
5.2 Americas Finasteride Oral Tablet Sales by Type
5.3 Americas Finasteride Oral Tablet Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Finasteride Oral Tablet Sales by Region
6.1.1 APAC Finasteride Oral Tablet Sales by Region (2017-2022)
6.1.2 APAC Finasteride Oral Tablet Revenue by Region (2017-2022)
6.2 APAC Finasteride Oral Tablet Sales by Type
6.3 APAC Finasteride Oral Tablet Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Finasteride Oral Tablet by Country
7.1.1 Europe Finasteride Oral Tablet Sales by Country (2017-2022)
7.1.2 Europe Finasteride Oral Tablet Revenue by Country (2017-2022)
7.2 Europe Finasteride Oral Tablet Sales by Type
7.3 Europe Finasteride Oral Tablet Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Finasteride Oral Tablet by Country
8.1.1 Middle East & Africa Finasteride Oral Tablet Sales by Country (2017-2022)
8.1.2 Middle East & Africa Finasteride Oral Tablet Revenue by Country (2017-2022)
8.2 Middle East & Africa Finasteride Oral Tablet Sales by Type
8.3 Middle East & Africa Finasteride Oral Tablet Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Finasteride Oral Tablet
10.3 Manufacturing Process Analysis of Finasteride Oral Tablet
10.4 Industry Chain Structure of Finasteride Oral Tablet
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Finasteride Oral Tablet Distributors
11.3 Finasteride Oral Tablet Customer
12 World Forecast Review for Finasteride Oral Tablet by Geographic Region
12.1 Global Finasteride Oral Tablet Market Size Forecast by Region
12.1.1 Global Finasteride Oral Tablet Forecast by Region (2023-2028)
12.1.2 Global Finasteride Oral Tablet Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Finasteride Oral Tablet Forecast by Type
12.7 Global Finasteride Oral Tablet Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Finasteride Oral Tablet Product Offered
13.1.3 Merck Finasteride Oral Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Accord Healthcare UK
13.2.1 Accord Healthcare UK Company Information
13.2.2 Accord Healthcare UK Finasteride Oral Tablet Product Offered
13.2.3 Accord Healthcare UK Finasteride Oral Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Accord Healthcare UK Main Business Overview
13.2.5 Accord Healthcare UK Latest Developments
13.3 Relonchem
13.3.1 Relonchem Company Information
13.3.2 Relonchem Finasteride Oral Tablet Product Offered
13.3.3 Relonchem Finasteride Oral Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Relonchem Main Business Overview
13.3.5 Relonchem Latest Developments
13.4 Sandoz
13.4.1 Sandoz Company Information
13.4.2 Sandoz Finasteride Oral Tablet Product Offered
13.4.3 Sandoz Finasteride Oral Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sandoz Main Business Overview
13.4.5 Sandoz Latest Developments
13.5 Teva Generics
13.5.1 Teva Generics Company Information
13.5.2 Teva Generics Finasteride Oral Tablet Product Offered
13.5.3 Teva Generics Finasteride Oral Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Teva Generics Main Business Overview
13.5.5 Teva Generics Latest Developments
13.6 Cipla
13.6.1 Cipla Company Information
13.6.2 Cipla Finasteride Oral Tablet Product Offered
13.6.3 Cipla Finasteride Oral Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Cipla Main Business Overview
13.6.5 Cipla Latest Developments
13.7 Dr. Reddy
13.7.1 Dr. Reddy Company Information
13.7.2 Dr. Reddy Finasteride Oral Tablet Product Offered
13.7.3 Dr. Reddy Finasteride Oral Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Dr. Reddy Main Business Overview
13.7.5 Dr. Reddy Latest Developments
13.8 Aurobindo Pharma
13.8.1 Aurobindo Pharma Company Information
13.8.2 Aurobindo Pharma Finasteride Oral Tablet Product Offered
13.8.3 Aurobindo Pharma Finasteride Oral Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Aurobindo Pharma Main Business Overview
13.8.5 Aurobindo Pharma Latest Developments
13.9 Henan Topfond
13.9.1 Henan Topfond Company Information
13.9.2 Henan Topfond Finasteride Oral Tablet Product Offered
13.9.3 Henan Topfond Finasteride Oral Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Henan Topfond Main Business Overview
13.9.5 Henan Topfond Latest Developments
13.10 Zhejiang CONBA Pharmaceutical
13.10.1 Zhejiang CONBA Pharmaceutical Company Information
13.10.2 Zhejiang CONBA Pharmaceutical Finasteride Oral Tablet Product Offered
13.10.3 Zhejiang CONBA Pharmaceutical Finasteride Oral Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Zhejiang CONBA Pharmaceutical Main Business Overview
13.10.5 Zhejiang CONBA Pharmaceutical Latest Developments
13.11 Shandong Renhetang Pharmaceutical
13.11.1 Shandong Renhetang Pharmaceutical Company Information
13.11.2 Shandong Renhetang Pharmaceutical Finasteride Oral Tablet Product Offered
13.11.3 Shandong Renhetang Pharmaceutical Finasteride Oral Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Shandong Renhetang Pharmaceutical Main Business Overview
13.11.5 Shandong Renhetang Pharmaceutical Latest Developments
13.12 Guangdong Eashu Pharmacetical
13.12.1 Guangdong Eashu Pharmacetical Company Information
13.12.2 Guangdong Eashu Pharmacetical Finasteride Oral Tablet Product Offered
13.12.3 Guangdong Eashu Pharmacetical Finasteride Oral Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Guangdong Eashu Pharmacetical Main Business Overview
13.12.5 Guangdong Eashu Pharmacetical Latest Developments
13.13 Shanghai Shyndec Pharmaceutical Co.,Ltd.
13.13.1 Shanghai Shyndec Pharmaceutical Co.,Ltd. Company Information
13.13.2 Shanghai Shyndec Pharmaceutical Co.,Ltd. Finasteride Oral Tablet Product Offered
13.13.3 Shanghai Shyndec Pharmaceutical Co.,Ltd. Finasteride Oral Tablet Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Shanghai Shyndec Pharmaceutical Co.,Ltd. Main Business Overview
13.13.5 Shanghai Shyndec Pharmaceutical Co.,Ltd. Latest Developments
14 Research Findings and Conclusion
Table 1. Finasteride Oral Tablet Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Finasteride Oral Tablet Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 1mg Tablet
Table 4. Major Players of 5mg Tablet
Table 5. Global Finasteride Oral Tablet Sales by Type (2017-2022) & (K Units)
Table 6. Global Finasteride Oral Tablet Sales Market Share by Type (2017-2022)
Table 7. Global Finasteride Oral Tablet Revenue by Type (2017-2022) & ($ million)
Table 8. Global Finasteride Oral Tablet Revenue Market Share by Type (2017-2022)
Table 9. Global Finasteride Oral Tablet Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Finasteride Oral Tablet Sales by Application (2017-2022) & (K Units)
Table 11. Global Finasteride Oral Tablet Sales Market Share by Application (2017-2022)
Table 12. Global Finasteride Oral Tablet Revenue by Application (2017-2022)
Table 13. Global Finasteride Oral Tablet Revenue Market Share by Application (2017-2022)
Table 14. Global Finasteride Oral Tablet Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Finasteride Oral Tablet Sales by Company (2020-2022) & (K Units)
Table 16. Global Finasteride Oral Tablet Sales Market Share by Company (2020-2022)
Table 17. Global Finasteride Oral Tablet Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Finasteride Oral Tablet Revenue Market Share by Company (2020-2022)
Table 19. Global Finasteride Oral Tablet Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Finasteride Oral Tablet Producing Area Distribution and Sales Area
Table 21. Players Finasteride Oral Tablet Products Offered
Table 22. Finasteride Oral Tablet Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Finasteride Oral Tablet Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Finasteride Oral Tablet Sales Market Share Geographic Region (2017-2022)
Table 27. Global Finasteride Oral Tablet Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Finasteride Oral Tablet Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Finasteride Oral Tablet Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Finasteride Oral Tablet Sales Market Share by Country/Region (2017-2022)
Table 31. Global Finasteride Oral Tablet Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Finasteride Oral Tablet Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Finasteride Oral Tablet Sales by Country (2017-2022) & (K Units)
Table 34. Americas Finasteride Oral Tablet Sales Market Share by Country (2017-2022)
Table 35. Americas Finasteride Oral Tablet Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Finasteride Oral Tablet Revenue Market Share by Country (2017-2022)
Table 37. Americas Finasteride Oral Tablet Sales by Type (2017-2022) & (K Units)
Table 38. Americas Finasteride Oral Tablet Sales Market Share by Type (2017-2022)
Table 39. Americas Finasteride Oral Tablet Sales by Application (2017-2022) & (K Units)
Table 40. Americas Finasteride Oral Tablet Sales Market Share by Application (2017-2022)
Table 41. APAC Finasteride Oral Tablet Sales by Region (2017-2022) & (K Units)
Table 42. APAC Finasteride Oral Tablet Sales Market Share by Region (2017-2022)
Table 43. APAC Finasteride Oral Tablet Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Finasteride Oral Tablet Revenue Market Share by Region (2017-2022)
Table 45. APAC Finasteride Oral Tablet Sales by Type (2017-2022) & (K Units)
Table 46. APAC Finasteride Oral Tablet Sales Market Share by Type (2017-2022)
Table 47. APAC Finasteride Oral Tablet Sales by Application (2017-2022) & (K Units)
Table 48. APAC Finasteride Oral Tablet Sales Market Share by Application (2017-2022)
Table 49. Europe Finasteride Oral Tablet Sales by Country (2017-2022) & (K Units)
Table 50. Europe Finasteride Oral Tablet Sales Market Share by Country (2017-2022)
Table 51. Europe Finasteride Oral Tablet Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Finasteride Oral Tablet Revenue Market Share by Country (2017-2022)
Table 53. Europe Finasteride Oral Tablet Sales by Type (2017-2022) & (K Units)
Table 54. Europe Finasteride Oral Tablet Sales Market Share by Type (2017-2022)
Table 55. Europe Finasteride Oral Tablet Sales by Application (2017-2022) & (K Units)
Table 56. Europe Finasteride Oral Tablet Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Finasteride Oral Tablet Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Finasteride Oral Tablet Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Finasteride Oral Tablet Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Finasteride Oral Tablet Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Finasteride Oral Tablet Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Finasteride Oral Tablet Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Finasteride Oral Tablet Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Finasteride Oral Tablet Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Finasteride Oral Tablet
Table 66. Key Market Challenges & Risks of Finasteride Oral Tablet
Table 67. Key Industry Trends of Finasteride Oral Tablet
Table 68. Finasteride Oral Tablet Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Finasteride Oral Tablet Distributors List
Table 71. Finasteride Oral Tablet Customer List
Table 72. Global Finasteride Oral Tablet Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Finasteride Oral Tablet Sales Market Forecast by Region
Table 74. Global Finasteride Oral Tablet Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Finasteride Oral Tablet Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Finasteride Oral Tablet Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Finasteride Oral Tablet Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Finasteride Oral Tablet Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Finasteride Oral Tablet Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Finasteride Oral Tablet Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Finasteride Oral Tablet Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Finasteride Oral Tablet Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Finasteride Oral Tablet Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Finasteride Oral Tablet Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Finasteride Oral Tablet Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Finasteride Oral Tablet Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Finasteride Oral Tablet Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Finasteride Oral Tablet Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Finasteride Oral Tablet Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Finasteride Oral Tablet Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Finasteride Oral Tablet Revenue Market Share Forecast by Application (2023-2028)
Table 92. Merck Basic Information, Finasteride Oral Tablet Manufacturing Base, Sales Area and Its Competitors
Table 93. Merck Finasteride Oral Tablet Product Offered
Table 94. Merck Finasteride Oral Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Merck Main Business
Table 96. Merck Latest Developments
Table 97. Accord Healthcare UK Basic Information, Finasteride Oral Tablet Manufacturing Base, Sales Area and Its Competitors
Table 98. Accord Healthcare UK Finasteride Oral Tablet Product Offered
Table 99. Accord Healthcare UK Finasteride Oral Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Accord Healthcare UK Main Business
Table 101. Accord Healthcare UK Latest Developments
Table 102. Relonchem Basic Information, Finasteride Oral Tablet Manufacturing Base, Sales Area and Its Competitors
Table 103. Relonchem Finasteride Oral Tablet Product Offered
Table 104. Relonchem Finasteride Oral Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Relonchem Main Business
Table 106. Relonchem Latest Developments
Table 107. Sandoz Basic Information, Finasteride Oral Tablet Manufacturing Base, Sales Area and Its Competitors
Table 108. Sandoz Finasteride Oral Tablet Product Offered
Table 109. Sandoz Finasteride Oral Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Sandoz Main Business
Table 111. Sandoz Latest Developments
Table 112. Teva Generics Basic Information, Finasteride Oral Tablet Manufacturing Base, Sales Area and Its Competitors
Table 113. Teva Generics Finasteride Oral Tablet Product Offered
Table 114. Teva Generics Finasteride Oral Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Teva Generics Main Business
Table 116. Teva Generics Latest Developments
Table 117. Cipla Basic Information, Finasteride Oral Tablet Manufacturing Base, Sales Area and Its Competitors
Table 118. Cipla Finasteride Oral Tablet Product Offered
Table 119. Cipla Finasteride Oral Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Cipla Main Business
Table 121. Cipla Latest Developments
Table 122. Dr. Reddy Basic Information, Finasteride Oral Tablet Manufacturing Base, Sales Area and Its Competitors
Table 123. Dr. Reddy Finasteride Oral Tablet Product Offered
Table 124. Dr. Reddy Finasteride Oral Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Dr. Reddy Main Business
Table 126. Dr. Reddy Latest Developments
Table 127. Aurobindo Pharma Basic Information, Finasteride Oral Tablet Manufacturing Base, Sales Area and Its Competitors
Table 128. Aurobindo Pharma Finasteride Oral Tablet Product Offered
Table 129. Aurobindo Pharma Finasteride Oral Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Aurobindo Pharma Main Business
Table 131. Aurobindo Pharma Latest Developments
Table 132. Henan Topfond Basic Information, Finasteride Oral Tablet Manufacturing Base, Sales Area and Its Competitors
Table 133. Henan Topfond Finasteride Oral Tablet Product Offered
Table 134. Henan Topfond Finasteride Oral Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Henan Topfond Main Business
Table 136. Henan Topfond Latest Developments
Table 137. Zhejiang CONBA Pharmaceutical Basic Information, Finasteride Oral Tablet Manufacturing Base, Sales Area and Its Competitors
Table 138. Zhejiang CONBA Pharmaceutical Finasteride Oral Tablet Product Offered
Table 139. Zhejiang CONBA Pharmaceutical Finasteride Oral Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Zhejiang CONBA Pharmaceutical Main Business
Table 141. Zhejiang CONBA Pharmaceutical Latest Developments
Table 142. Shandong Renhetang Pharmaceutical Basic Information, Finasteride Oral Tablet Manufacturing Base, Sales Area and Its Competitors
Table 143. Shandong Renhetang Pharmaceutical Finasteride Oral Tablet Product Offered
Table 144. Shandong Renhetang Pharmaceutical Finasteride Oral Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Shandong Renhetang Pharmaceutical Main Business
Table 146. Shandong Renhetang Pharmaceutical Latest Developments
Table 147. Guangdong Eashu Pharmacetical Basic Information, Finasteride Oral Tablet Manufacturing Base, Sales Area and Its Competitors
Table 148. Guangdong Eashu Pharmacetical Finasteride Oral Tablet Product Offered
Table 149. Guangdong Eashu Pharmacetical Finasteride Oral Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Guangdong Eashu Pharmacetical Main Business
Table 151. Guangdong Eashu Pharmacetical Latest Developments
Table 152. Shanghai Shyndec Pharmaceutical Co.,Ltd. Basic Information, Finasteride Oral Tablet Manufacturing Base, Sales Area and Its Competitors
Table 153. Shanghai Shyndec Pharmaceutical Co.,Ltd. Finasteride Oral Tablet Product Offered
Table 154. Shanghai Shyndec Pharmaceutical Co.,Ltd. Finasteride Oral Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Shanghai Shyndec Pharmaceutical Co.,Ltd. Main Business
Table 156. Shanghai Shyndec Pharmaceutical Co.,Ltd. Latest Developments
List of Figures
Figure 1. Picture of Finasteride Oral Tablet
Figure 2. Finasteride Oral Tablet Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Finasteride Oral Tablet Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Finasteride Oral Tablet Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Finasteride Oral Tablet Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 1mg Tablet
Figure 10. Product Picture of 5mg Tablet
Figure 11. Global Finasteride Oral Tablet Sales Market Share by Type in 2021
Figure 12. Global Finasteride Oral Tablet Revenue Market Share by Type (2017-2022)
Figure 13. Finasteride Oral Tablet Consumed in Benign Prostatic Hyperplasia
Figure 14. Global Finasteride Oral Tablet Market: Benign Prostatic Hyperplasia (2017-2022) & (K Units)
Figure 15. Finasteride Oral Tablet Consumed in Male Pattern Baldness
Figure 16. Global Finasteride Oral Tablet Market: Male Pattern Baldness (2017-2022) & (K Units)
Figure 17. Finasteride Oral Tablet Consumed in Others
Figure 18. Global Finasteride Oral Tablet Market: Others (2017-2022) & (K Units)
Figure 19. Global Finasteride Oral Tablet Sales Market Share by Application (2017-2022)
Figure 20. Global Finasteride Oral Tablet Revenue Market Share by Application in 2021
Figure 21. Finasteride Oral Tablet Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Finasteride Oral Tablet Revenue Market Share by Company in 2021
Figure 23. Global Finasteride Oral Tablet Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Finasteride Oral Tablet Revenue Market Share by Geographic Region in 2021
Figure 25. Global Finasteride Oral Tablet Sales Market Share by Region (2017-2022)
Figure 26. Global Finasteride Oral Tablet Revenue Market Share by Country/Region in 2021
Figure 27. Americas Finasteride Oral Tablet Sales 2017-2022 (K Units)
Figure 28. Americas Finasteride Oral Tablet Revenue 2017-2022 ($ Millions)
Figure 29. APAC Finasteride Oral Tablet Sales 2017-2022 (K Units)
Figure 30. APAC Finasteride Oral Tablet Revenue 2017-2022 ($ Millions)
Figure 31. Europe Finasteride Oral Tablet Sales 2017-2022 (K Units)
Figure 32. Europe Finasteride Oral Tablet Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Finasteride Oral Tablet Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Finasteride Oral Tablet Revenue 2017-2022 ($ Millions)
Figure 35. Americas Finasteride Oral Tablet Sales Market Share by Country in 2021
Figure 36. Americas Finasteride Oral Tablet Revenue Market Share by Country in 2021
Figure 37. United States Finasteride Oral Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Finasteride Oral Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Finasteride Oral Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Finasteride Oral Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Finasteride Oral Tablet Sales Market Share by Region in 2021
Figure 42. APAC Finasteride Oral Tablet Revenue Market Share by Regions in 2021
Figure 43. China Finasteride Oral Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Finasteride Oral Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Finasteride Oral Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Finasteride Oral Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Finasteride Oral Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Finasteride Oral Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Finasteride Oral Tablet Sales Market Share by Country in 2021
Figure 50. Europe Finasteride Oral Tablet Revenue Market Share by Country in 2021
Figure 51. Germany Finasteride Oral Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Finasteride Oral Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Finasteride Oral Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Finasteride Oral Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Finasteride Oral Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Finasteride Oral Tablet Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Finasteride Oral Tablet Revenue Market Share by Country in 2021
Figure 58. Egypt Finasteride Oral Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Finasteride Oral Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Finasteride Oral Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Finasteride Oral Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Finasteride Oral Tablet Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Finasteride Oral Tablet in 2021
Figure 64. Manufacturing Process Analysis of Finasteride Oral Tablet
Figure 65. Industry Chain Structure of Finasteride Oral Tablet
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...